Yahoo Web Search

Search results

1. www.google.com › finance › quoteCureVac BV (CVAC) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest CureVac BV (CVAC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

2. CUREVAC

   Milan: 1CVAC.MI

   4.3120

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.3000 (-6.50%)

   · Delayed Quote (EUR) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	4.6980
     High	4.6980
     Low	4.2820

   • Mkt Cap	N/A
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	4.6120
     52 Wk. Low	2.1600
     52 Wk. High	5.4400

   More about 1CVAC.MI

   More on Yahoo Finance

3. finance.yahoo.com › quote › CVACCureVac N.V. (CVAC) Stock Price, News, Quote & History ...

   finance.yahoo.com › quote › CVAC

   • Cached

   Find the latest CureVac N.V. (CVAC) stock quote, history, news and other vital information to help you with your stock trading and investing.

4. www.macrotrends.net › CVAC › curevacCureVac Net Worth 2021-2023 | CVAC | MacroTrends

   www.macrotrends.net › CVAC › curevac

   • Cached

   CureVac net worth as of March 20, 2024 is $0.68B. Compare CVAC With Other Stocks. Interactive chart of historical net worth (market cap) for CureVac (CVAC) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding.

5. www.wallstreetzen.com › stocks › usCurevac Nv Stock Price Today (NASDAQ: CVAC ... - WallStreetZen

   www.wallstreetzen.com › stocks › us

   • Cached

   2 days ago · How much is Curevac Nv stock worth today? ( NASDAQ : CVAC ) Curevac Nv currently has 224,305,680 outstanding shares. With Curevac Nv stock trading at $4.99 per share, the total value of Curevac Nv stock (market capitalization) is $1.12B .

6. www.marketwatch.com › investing › stockCVAC Stock Price | CureVac N.V. Stock Quote (U.S.: Nasdaq ...

   www.marketwatch.com › investing › stock

   2 days ago · Incyte Corp. -1.05%. $13.27B. CVAC | Complete CureVac N.V. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

   • 1 Month: 15.74%
   • 5 Day: 12.88%

   • 3 Month: 32.19%
   • YTD: 38.95%

7. stockanalysis.com › stocks › cvacCureVac N.V. (CVAC) Stock Price, Quote & News - Stock Analysis

   stockanalysis.com › stocks › cvac

   • Cached

   2 days ago · Get a real-time CureVac N.V. (CVAC) stock price quote with breaking news, financials, statistics, charts and more.

8. People also ask

   Is CureVac (CVac) a good stock to buy now?

   • For example, although Amazon.com made... CureVac N.V. (CVAC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

   CureVac N.V. (CVAC) stock price, news, quote & history - Yahoo Finance

   uk.finance.yahoo.com/quote/CVAC/

   See all results for this question

   What is the fair value of CureVac (CVAC) shares?

   • In a note out Thursday, Guggenheim analyst Seamus Fernandez wrote that he now estimates a fair-value range for CureVac (ticker: CVAC) shares of between $15 and $30 per share, down from his previous estimate of between $90 and $110. That...

   CureVac Stock Fell 39% After Its Vaccine Failure. The Pain May Just Be G…

   www.barrons.com/articles/curevac-stock-covid-19-vaccine-51623934158

   See all results for this question

   Is CureVac a safe biotech?

   • At a $10 billion market cap, CureVac's pipeline (which includes a potential rabies vaccine in phase 1 trials) is in its infancy, and its coronavirus vaccine candidate is questionable. It is definitely not a safe biotech for investors to buy anytime soon. Zhiyuan Sun has no position in any of the stocks mentioned.

   Why Is Everyone Talking About CureVac Stock? | The Motley Fool

   www.fool.com/investing/2021/06/21/why-is-everyone-talking-about-curevac-stock/

   See all results for this question

   What do we know about CureVac?

   • Here’s what we know… Dr. Ingmar Hoerr founded CureVac in 2000. It’s a leading biotech company based in Tübingen, Germany. The company uses messenger RNA (mRNA) technology. It helps develop cancer therapies and treatments for rare diseases. CureVac started working on its first mRNA-based vaccine in 2011.

   CureVac IPO: Coronavirus Vaccine Firm Going Public?

   investmentu.com/curevac-ipo-coronavirus-vaccine-going-public/

   See all results for this question

9. finviz.com › quoteCVAC - CureVac N.V. Stock Price and Quote - FINVIZ.com

   finviz.com › quote

   • Cached

   CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.